IE930109L - LHRH Peptide Derivatives - Google Patents

LHRH Peptide Derivatives

Info

Publication number
IE930109L
IE930109L IE930109A IE930109A IE930109L IE 930109 L IE930109 L IE 930109L IE 930109 A IE930109 A IE 930109A IE 930109 A IE930109 A IE 930109A IE 930109 L IE930109 L IE 930109L
Authority
IE
Ireland
Prior art keywords
sugar residue
omega
amino group
attached
peptide
Prior art date
Application number
IE930109A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808275A external-priority patent/GB8808275D0/en
Priority claimed from GB888808528A external-priority patent/GB8808528D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE930109L publication Critical patent/IE930109L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IE930109A 1988-04-08 1989-04-07 LHRH Peptide Derivatives IE930109L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808275A GB8808275D0 (en) 1988-04-08 1988-04-08 New calcitonin derivatives
GB888808528A GB8808528D0 (en) 1988-04-12 1988-04-12 Peptide derivatives

Publications (1)

Publication Number Publication Date
IE930109L true IE930109L (en) 1989-10-08

Family

ID=26293749

Family Applications (1)

Application Number Title Priority Date Filing Date
IE930109A IE930109L (en) 1988-04-08 1989-04-07 LHRH Peptide Derivatives

Country Status (19)

Country Link
US (1) US5541159A (enExample)
JP (2) JPH01305099A (enExample)
AT (1) ATA900689A (enExample)
AU (2) AU3362889A (enExample)
BE (1) BE1004357A4 (enExample)
CH (1) CH682152A5 (enExample)
DK (1) DK163689A (enExample)
ES (1) ES2015645A6 (enExample)
FR (1) FR2629825B1 (enExample)
GB (1) GB2218102B (enExample)
IE (1) IE930109L (enExample)
IL (1) IL89881A (enExample)
IT (1) IT1235894B (enExample)
LU (1) LU87495A1 (enExample)
MY (1) MY108554A (enExample)
NL (1) NL8900864A (enExample)
NZ (1) NZ228677A (enExample)
SE (1) SE8901241L (enExample)
WO (1) WO1989009786A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives
DE3842010A1 (de) * 1988-12-14 1990-06-21 Hoechst Ag Kompetitive gonadoliberin-antagonisten
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
DK0477499T3 (da) * 1990-08-04 1994-05-30 Hoechst Ag Gonadoliberin-antagonister
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
EP0632813B1 (en) * 1992-02-13 1999-12-15 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
JPH07506344A (ja) * 1992-02-13 1995-07-13 トルフ　エスタブリッシュメント アマドリ反応化合物と生産物、その製造プロセスとその使用
FR2695391B1 (fr) * 1992-09-04 1994-10-14 Centre Nat Rech Scient Glycopeptides, leur procédé d'obtention, et leurs applications biologiques.
JP2944419B2 (ja) * 1993-05-10 1999-09-06 ノバルティス アクチエンゲゼルシャフト 持続性遊離組成物中の薬理学的活性成分の安定
EP0698040A4 (en) * 1993-05-20 1999-01-07 Biotech Australia Pty Ltd LHRH ANTAGONISTS
ATE284413T1 (de) * 1993-08-09 2004-12-15 Sod Conseils Rech Applic Therapeutische peptid derivate
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
CA2261974A1 (en) 1996-07-25 1998-02-05 Biogen, Inc. Molecular model for vla-4 inhibitors
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
US6083480A (en) 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
AU766653B2 (en) 1998-02-13 2003-10-23 Amylin Pharmaceuticals, Inc. Novel mixed amylin activity compounds
AU764108B2 (en) 1998-05-28 2003-08-07 Biogen Idec Ma Inc. A novel VLA-4 inhibitor: oMePUPA-V
GEP20053477B (en) 1999-08-13 2005-03-25 Biogen Inc Cell Adhesion Inhibitors and Pharmaceutical Compositions Containing Them
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法
GB201813677D0 (en) * 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
TW202320857A (zh) * 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4650854A (en) * 1985-06-06 1987-03-17 Usv Pharmaceutical Corporation Amide analogs of calcitonin
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives

Also Published As

Publication number Publication date
DK163689D0 (da) 1989-04-05
ATA900689A (de) 1997-01-15
MY108554A (en) 1996-10-31
WO1989009786A1 (en) 1989-10-19
AU3263789A (en) 1989-10-12
NZ228677A (en) 1994-08-26
GB2218102A (en) 1989-11-08
SE8901241D0 (sv) 1989-04-07
GB2218102B (en) 1992-09-16
CH682152A5 (enExample) 1993-07-30
IT1235894B (it) 1992-11-23
FR2629825B1 (fr) 1993-05-14
BE1004357A4 (fr) 1992-11-10
AU3362889A (en) 1989-11-03
IL89881A (en) 1994-05-30
ES2015645A6 (es) 1990-09-01
IL89881A0 (en) 1989-12-15
LU87495A1 (fr) 1989-11-14
US5541159A (en) 1996-07-30
IT8947823A0 (it) 1989-04-07
NL8900864A (nl) 1989-11-01
FR2629825A1 (fr) 1989-10-13
AU623385B2 (en) 1992-05-14
DK163689A (da) 1989-10-30
GB8907652D0 (en) 1989-05-17
JPH0789994A (ja) 1995-04-04
JPH01305099A (ja) 1989-12-08
SE8901241L (sv) 1990-02-02

Similar Documents

Publication Publication Date Title
IE930109L (en) LHRH Peptide Derivatives
CA2122717A1 (en) Hemoglobins as drug delivery agents
DE69432758D1 (en) Therapeutisch wirksame peptidderivate
CA2004532A1 (en) Peptide derivatives
FR2665951B1 (fr) Systeme de liaison cassable permettant de separer des pieces au moyen d'une charge detonante.
EP0374120A3 (en) Comosition for controlled release of polypeptides
EP1705190A3 (en) Peptide derivatives
CA2315733A1 (en) Type 2 helper t cell-selective immune response inhibitors
IL132380A0 (en) Compositions comprising conjugates of stable active human ob protein with antibody fc chain and methods
CA2032499A1 (en) Polypeptide derivatives
EP0356124A3 (en) Atrial natriuretic peptide clearance inhibitors
CA2093125A1 (en) Angiotensin ii antagonists
WO2000023094A3 (en) Methods of inhibiting platelet activation and recruitment
AU5780890A (en) Tetrazole excitatory amino acid receptor antagonists
EP0384341A3 (en) New proline derivatives
WO1995016040A3 (en) Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
AU5436790A (en) Sulfer-containing xanthine derivatives as adenosin antagonists
EP0372503A3 (en) Anticoagulant peptides
WO2000040225A3 (en) Inhibition of tnf activity
AU5749198A (en) Crystallisation of proteins
AU3868189A (en) Aminoalkylaminocarbonyl aminodiol amino acid derivatives as anti-hypertensive agents
EP0390181A3 (en) Perylenequinone (UCN-1028D) derivatives
Albert et al. Calcitonin derivatives
ES285467U (es) Dispositivo de fijacion de cangilones sobre la bada de un transportador, especialmente de un elevador a cangilones
Baxter Detroit Takes Hard Look at Ceramic Applications